A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence

• Published in: Scientific reports Vol. 14; no. 1; pp. 16391 - 13
• Main Authors: Soeda, Yoshiyuki, Hayashi, Emi, Nakatani, Naoko, Ishigaki, Shinsuke, Takaichi, Yuta, Tachibana, Taro, Riku, Yuichi, Chambers, James K., Koike, Riki, Mohammad, Moniruzzaman, Takashima, Akihiko
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.07.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/1689/1283; 631/80/470/2284; Aggregates; Alzheimer's disease; Amino acid sequence; Amino acids; Antibody; C-terminal regions of tau; Epitopes; Fibrillogenesis; Granular tau oligomers; Humanities and Social Sciences; Immunization; Immunoreactivity; Monoclonal antibodies; multidisciplinary; Neurodegenerative diseases; Neurofibrillary tangles; Oligomers; Prefrontal cortex; Science; Science (multidisciplinary); Tau aggregation; Tau protein; Transgenic mice; Granular tau oligomers; C-terminal regions of tau; Antibody; Tau aggregation
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-65949-7

Prior to the formation of amyloid fibrils, the pathological hallmark in tau-related neurodegenerative disease, tau monomers aggregate into a diverse range of oligomers. Granular tau oligomers, consisting of approximately 40 tau protein molecules, are present in the prefrontal cortex of patients at Braak stages I-II, preclinical stages of Alzheimer’s disease (AD). Antibodies to granular tau oligomers as antigens have not been reported. Therefore, we generated new rat monoclonal antibodies by immunization with granular tau oligomers. Three antibodies from different hybridoma clones showed stronger immunoreactivity to granular tau oligomers and tau fibrils compared with monomeric tau. Of the three antibodies, 2D6-2C6 showed 3000-fold greater immunoreactivity in P301L-tau transgenic (rTg4510) mice than in non-transgenic mice, while MC1 antibody, which detects pathological conformations of tau, showed a 5.5-fold increase. These results suggest that 2D6-2C6 recognizes aggregates more specifically than MC1. In AD subjects, 2D6-2C6 recognized neurofibrillary tangles and pretangles, and co-localized within AT8-positive cells containing phosphorylated tau aggregates. The epitope of 2D6-2C6 is the 423–430 amino acid (AA) sequence of C-terminal regions. Taken together, a novel monoclonal antibody, 2D6-2C6, generated by immunization with granular tau oligomers binds to tau aggregates at the 423–430 AA sequence.